Tocilizumab: Viral myocarditis, increased viral replication and worsening of COVID-19 following off-label use: 2 case reports

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366435/
http://dx.doi.org/10.1007/s40278-020-80977-9
_version_ 1783560220801236992
collection PubMed
description
format Online
Article
Text
id pubmed-7366435
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73664352020-07-17 Tocilizumab: Viral myocarditis, increased viral replication and worsening of COVID-19 following off-label use: 2 case reports Reactions Weekly Case Report Springer International Publishing 2020-07-18 2020 /pmc/articles/PMC7366435/ http://dx.doi.org/10.1007/s40278-020-80977-9 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Tocilizumab: Viral myocarditis, increased viral replication and worsening of COVID-19 following off-label use: 2 case reports
title Tocilizumab: Viral myocarditis, increased viral replication and worsening of COVID-19 following off-label use: 2 case reports
title_full Tocilizumab: Viral myocarditis, increased viral replication and worsening of COVID-19 following off-label use: 2 case reports
title_fullStr Tocilizumab: Viral myocarditis, increased viral replication and worsening of COVID-19 following off-label use: 2 case reports
title_full_unstemmed Tocilizumab: Viral myocarditis, increased viral replication and worsening of COVID-19 following off-label use: 2 case reports
title_short Tocilizumab: Viral myocarditis, increased viral replication and worsening of COVID-19 following off-label use: 2 case reports
title_sort tocilizumab: viral myocarditis, increased viral replication and worsening of covid-19 following off-label use: 2 case reports
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366435/
http://dx.doi.org/10.1007/s40278-020-80977-9

Ejemplares similares